Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Petmed Express (DE:PQM)
FRANKFURT:PQM
Holding DE:PQM?
Track your performance easily
PQM Stock Chart & Stats
Day’s Range― - ―
52-Week Range€2.60 - €6.26
Previous CloseN/A
Volume0.00
Average Volume (3M)13.00
Market Cap
$97.77M
Enterprise Value€26.23M
Total Cash (Recent Filing)$58.73M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Jan 28, 2025EPS Estimate
<0.01Last Dividend Ex-Date
Aug 11, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,663,218
10 Day Avg. Volume0
30 Day Avg. Volume13
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.40
Price to Cash Flow (P/CF)3.50
P/FCF Ratio4.20
Enterprise Value/Market Cap0.27
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit0.33
Enterprise Value/Ebitda3.97
Forecast
1Y Price Target
€3.60Price Target Upside-20.91% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Petmed Express News
PremiumCompany Announcements
PetMed Express Implements Shareholder Rights Protection Plan
PremiumCompany Announcements
PetMed Express Reports Strong Profit Growth in Q2
PremiumCompany Announcements
PetMed Express Launches New 2024 Talent Incentive Plan
PremiumCompany Announcements
PetMed Express Welcomes New CFO Robyn D’Elia for Growth
Ownership Overview
16.39% Insiders
15.05% Mutual Funds
0.01% Other Institutional Investors
61.87% Public Companies and Individual Investors
Website Traffic
The estimated number of people who visited one or more of the websites owned by Petmed Express
Desktop Users
Mobile Users
PQM FAQ
What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was €2.60 and its highest was €6.26 in the past 12 months.
What is Petmed Express’s market cap?
Petmed Express’s market cap is $97.77M.
When is Petmed Express’s upcoming earnings report date?
Petmed Express’s upcoming earnings report date is Jan 28, 2025 which is 3 days ago.
How were Petmed Express’s earnings last quarter?
Petmed Express released its earnings results on Nov 06, 2024. The company reported €0.106 earnings per share for the quarter, beating the consensus estimate of -€0.053 by €0.158.
Is Petmed Express overvalued?
According to Wall Street analysts Petmed Express’s price is currently Overvalued.
Does Petmed Express pay dividends?
Petmed Express pays a Quarterly dividend of €0.288 which represents an annual dividend yield of N/A. See more information on Petmed Express dividends here
What is Petmed Express’s EPS estimate?
Petmed Express’s EPS estimate is <0.01.
How many shares outstanding does Petmed Express have?
Petmed Express has 20,663,218 shares outstanding.
What happened to Petmed Express’s price movement after its last earnings report?
Petmed Express reported an EPS of €0.106 in its last earnings report, beating expectations of -€0.053. Following the earnings report the stock price went down -0.434%.
Which hedge fund is a major shareholder of Petmed Express?
Among the largest hedge funds holding Petmed Express’s share is Hotchkis & Wiley Capital Management LLC. It holds Petmed Express’s shares valued at 4M.
---
Petmed Express Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
€3.60 (-20.91% Downside)
€3.60 (-20.91% Downside)
Blogger Sentiment
Bullish
DE:PQM Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.35%
12-Months-Change
Fundamentals
Return on Equity
-0.98%
Trailing 12-Months
Asset Growth
-10.24%
Trailing 12-Months
Company Description
Petmed Express
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
---
PQM Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted improvements in gross margin, adjusted EBITDA, and customer experience, driven by effective cost reduction initiatives and technology upgrades. However, the company experienced a notable decline in sales and is facing pressure from a heavily promotional environment. The reduction in marketing spend has also impacted customer acquisition efforts.Read More>---
PQM Stock 12 Month Forecast
Average Price Target
€3.60
▼(-20.91% Downside)
Technical Analysis
Best Analysts Covering PQM
1 Year
1 Year Success Rate
11/18 ratings generated profit
1 Year Average Return
+4.26%
reiterated a sell rating 3 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +4.26% per trade.
---